|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Isomerase/DNA
|
 |
|
Title:
|
 |
Structural insight into the quinolone-DNA cleavage complex of type iia topoisomerases
|
|
Structure:
|
 |
DNA topoisomerase 4 subunit a. Chain: a, b. Fragment: residues 1-488. Synonym: parc55, topoisomerase iv subunit a. Engineered: yes. DNA topoisomerase 4 subunit b. Chain: c, d. Fragment: residues 404-647. Synonym: pare30, topoisomerase iv subunit b.
|
|
Source:
|
 |
Streptococcus pneumoniae. Organism_taxid: 1313. Gene: parc, sp_0855. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: pare, sp_0852. Synthetic: yes. Synthetic: yes
|
|
Resolution:
|
 |
|
4.00Å
|
R-factor:
|
0.264
|
R-free:
|
0.313
|
|
|
Authors:
|
 |
I.Laponogov,M.K.Sohi,D.A.Veselkov,X.-S.Pan,R.Sawhney, A.W.Thompson,K.E.Mcauley,L.M.Fisher,M.R.Sanderson
|
Key ref:
|
 |
I.Laponogov
et al.
(2009).
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases.
Nat Struct Biol,
16,
667-669.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
30-Dec-08
|
Release date:
|
24-Feb-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
chromosome
|
1 term
|
 |
|
Biological process
|
DNA metabolic process
|
3 terms
|
 |
|
Biochemical function
|
DNA binding
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
16:667-669
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases.
|
|
I.Laponogov,
M.K.Sohi,
D.A.Veselkov,
X.S.Pan,
R.Sawhney,
A.W.Thompson,
K.E.McAuley,
L.M.Fisher,
M.R.Sanderson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Type II topoisomerases alter DNA topology by forming a covalent DNA-cleavage
complex that allows DNA transport through a double-stranded DNA break. We
present the structures of cleavage complexes formed by the Streptococcus
pneumoniae ParC breakage-reunion and ParE TOPRIM domains of topoisomerase IV
stabilized by moxifloxacin and clinafloxacin, two antipneumococcal
fluoroquinolones. These structures reveal two drug molecules intercalated at the
highly bent DNA gate and help explain antibacterial quinolone action and
resistance.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
(a) Domain organization of S. pneumoniae topo IV. (b,c) Front
(b) and top (c) views of the topo IV ParC55 and ParE30 proteins
complexed with the G-segment DNA and a quinolone drug
(moxifloxacin), shown both in surface (above) and detailed
cartoon (below) representations. DNA is in green, the TOPRIM
domain (ParE30) is in yellow and the ParC55 is in blue. The drug
molecules are shown in red. The WHD, 'tower' and C-gate are
shown in cyan, orange and silver, respectively. The interface
region between ParC and ParE subunits (involving the 1
helix) is in purple. (d,e) Chemical representation of
moxifloxacin (d) and clinafloxacin (e), respectively. Generated
using VMD^20 and POV-Ray (http://www.povray.org).
|
 |
Figure 2.
(a) Front, top and side views of the cleavage complex active
site in cartoon representation. The 4
helices are shown in blue. Moxifloxacin is in red. The DNA
G-segment is in green with the backbone positions relative to
the cleavage point, indicated by yellow numbers in green
circles. The active site tyrosines (Tyr118) are in orange and
the residues thought to be involved in coordination of the
active site magnesium ion are shown in purple. The residues
responsible for drug resistance upon mutation are shown in
yellow—Ser79 and Asp83 are located within the 4
helix of ParC WHD, whereas Glu474, Glu475, Arg456 and Asp435 (A,
D, B and C, respectively) reside within the TOPRIM domain of
ParE. The rest of the protein molecule is shown in silver.
Rendered using VMD and Pov-Ray. (b) Top, bottom and side views
of the cleaved G-segment DNA molecule (green) tethered to the
active site tyrosines (orange) with the moxifloxacin (red)
molecules intercalated. The superimposed [A]-weighted
2F[o] – F[c] (blue) and F[o] – F[c] (yellow) electron
density maps are contoured at 1.5 and
3.2 ,
respectively. Rendered using WinCoot^21 and POV-Ray
(http://www.povray.org/).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(2009,
16,
667-669)
copyright 2009.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.M.Baker,
S.Weigand,
S.Maar-Mathias,
and
A.Mondragón
(2011).
Solution structures of DNA-bound gyrase.
|
| |
Nucleic Acids Res, 39,
755-766.
|
 |
|
|
|
|
 |
P.Singh,
P.Verma,
B.Yadav,
and
S.S.Komath
(2011).
Synthesis and evaluation of indole-based new scaffolds for antimicrobial activities-Identification of promising candidates.
|
| |
Bioorg Med Chem Lett, 21,
3367-3372.
|
 |
|
|
|
|
 |
S.Heeb,
M.P.Fletcher,
S.R.Chhabra,
S.P.Diggle,
P.Williams,
and
M.Cámara
(2011).
Quinolones: from antibiotics to autoinducers.
|
| |
FEMS Microbiol Rev, 35,
247-274.
|
 |
|
|
|
|
 |
X.Xiong,
E.H.Bromley,
P.Oelschlaeger,
D.N.Woolfson,
and
J.Spencer
(2011).
Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a gram-negative bacterium.
|
| |
Nucleic Acids Res, 39,
3917-3927.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Chai,
J.Wang,
M.Liu,
H.Yi,
L.Sun,
X.You,
and
H.Guo
(2011).
Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives.
|
| |
Bioorg Med Chem Lett, 21,
3377-3380.
|
 |
|
|
|
|
 |
A.J.Schoeffler,
A.P.May,
and
J.M.Berger
(2010).
A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function.
|
| |
Nucleic Acids Res, 38,
7830-7844.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Wohlkonig,
P.F.Chan,
A.P.Fosberry,
P.Homes,
J.Huang,
M.Kranz,
V.R.Leydon,
T.J.Miles,
N.D.Pearson,
R.L.Perera,
A.J.Shillings,
M.N.Gwynn,
and
B.D.Bax
(2010).
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance.
|
| |
Nat Struct Mol Biol, 17,
1152-1153.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.D.Bax,
P.F.Chan,
D.S.Eggleston,
A.Fosberry,
D.R.Gentry,
F.Gorrec,
I.Giordano,
M.M.Hann,
A.Hennessy,
M.Hibbs,
J.Huang,
E.Jones,
J.Jones,
K.K.Brown,
C.J.Lewis,
E.W.May,
M.R.Saunders,
O.Singh,
C.E.Spitzfaden,
C.Shen,
A.Shillings,
A.J.Theobald,
A.Wohlkonig,
N.D.Pearson,
and
M.N.Gwynn
(2010).
Type IIA topoisomerase inhibition by a new class of antibacterial agents.
|
| |
Nature, 466,
935-940.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Sissi,
E.Vazquez,
A.Chemello,
L.A.Mitchenall,
A.Maxwell,
and
M.Palumbo
(2010).
Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB.
|
| |
Antimicrob Agents Chemother, 54,
213-220.
|
 |
|
|
|
|
 |
C.Sissi,
and
M.Palumbo
(2010).
In front of and behind the replication fork: bacterial type IIA topoisomerases.
|
| |
Cell Mol Life Sci, 67,
2001-2024.
|
 |
|
|
|
|
 |
I.Laponogov,
X.S.Pan,
D.A.Veselkov,
K.E.McAuley,
L.M.Fisher,
and
M.R.Sanderson
(2010).
Structural basis of gate-DNA breakage and resealing by type II topoisomerases.
|
| |
PLoS One, 5,
e11338.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Piton,
S.Petrella,
M.Delarue,
G.André-Leroux,
V.Jarlier,
A.Aubry,
and
C.Mayer
(2010).
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
|
| |
PLoS One, 5,
e12245.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Pommier,
E.Leo,
H.Zhang,
and
C.Marchand
(2010).
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
|
| |
Chem Biol, 17,
421-433.
|
 |
|
|
|
|
 |
M.J.Edwards,
R.H.Flatman,
L.A.Mitchenall,
C.E.Stevenson,
T.B.Le,
T.A.Clarke,
A.R.McKay,
H.P.Fiedler,
M.J.Buttner,
D.M.Lawson,
and
A.Maxwell
(2009).
A crystal structure of the bifunctional antibiotic simocyclinone d8, bound to DNA gyrase.
|
| |
Science, 326,
1415-1418.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.S.Pan,
K.A.Gould,
and
L.M.Fisher
(2009).
Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.
|
| |
Antimicrob Agents Chemother, 53,
3822-3831.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|